Cargando…
Globo H Is a Promising Theranostic Marker for Intrahepatic Cholangiocarcinoma
Recent studies support the development of cancer therapeutics to target Globo H‐ceramide, the most prevalent tumor‐associated carbohydrate antigen in epithelial cancers. Herein, we evaluated the expression of Globo H and its prognostic significance in intrahepatic cholangiocarcinoma (ICC) and conduc...
Autores principales: | Hung, Tsai‐Hsien, Hung, Jung‐Tung, Wu, Chiao‐En, Huang, Yenlin, Lee, Chien‐Wei, Yeh, Chau‐Ting, Chung, Yi‐Hsiu, Lo, Fei‐Yun, Lai, Li‐Chun, Tung, John K., Yu, John, Yeh, Chun‐Nan, Yu, Alice L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710794/ https://www.ncbi.nlm.nih.gov/pubmed/34558839 http://dx.doi.org/10.1002/hep4.1800 |
Ejemplares similares
-
Hepatectomy or/with Metastatectomy for Recurrent Intrahepatic Cholangiocarcinoma: Of Promise for Selected Patients
por: Tsai, Chun-Yi, et al.
Publicado: (2022) -
Peritumoral SPARC expression and patient outcome with resectable intrahepatic cholangiocarcinoma
por: Cheng, Chi-Tung, et al.
Publicado: (2015) -
The clinical relevance of humoral immune responses to Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 and expression of Globo H in metastatic breast cancer
por: Hung, Jung-Tung, et al.
Publicado: (2022) -
Lipocalin 2 (LCN2) is a promising target for cholangiocarcinoma treatment and bile LCN2 level is a potential cholangiocarcinoma diagnostic marker
por: Chiang, Kun-Chun, et al.
Publicado: (2016) -
Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence
por: Chan, Kun-Ming, et al.
Publicado: (2018)